List of Tables
Table 2.1 Key Benefits of Precision Medicine
Table 2.2 Key Elements of Precision Medicine
Table 4.1 Key Benefits of Precision Medicine for Patients
Table 4.2 Key Laws & Regulatory Bodies in the Precision Medicine Industry
Table 4.3 Key Consortiums in the Precision Medicine Industry
Table 4.4 Key Alliances/Associations in the Precision Medicine Industry
Table 5.1 Global Precision Medicine Market Forecast by End-Users: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 5.2 Global Pharma & Biotech Companies End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 5.3 Key Developments in Pharma & Biotech Companies
Table 5.4 Global Diagnostic Tool Companies End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 5.5 Key Developments in Diagnostic Companies
Table 5.6 Global Healthcare ITs/Big Data End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 5.7 Key Developments in Healthcare IT/Big Data Companies
Table 5.8 Global Clinical Laboratories Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.1 Global Precision Medicine Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.2 Global Companion Diagnostics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.3 List of Approved Companion Diagnostic Devices
Table 6.4 Global Biomarkers Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.5 List of Biobanks
Table 6.6 Examples of Biobanking Initiatives Across Selected OECD Countries
Table 6.7 Global Biobanking in Targeted Therapeutics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.8 Global Pharmacogenomics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.9 Market Developments
Table 6.10 Global Molecular Diagnostics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.11 Some Examples of Human Genetic Tests That Have Been Approved by the FDA
Table 6.12 Some Examples of Microbial Tests That Have Been Approved by the FDA
Table 7.1 Global Precision Medicine Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 7.2 Global Cancer Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 7.3 Precision Medicine Drugs and Relevant Genes: Oncology
Table 7.4 Precision Medicine Genetic Tests with Respect to Oncology
Table 7.5 Key Developments
Table 7.6 Global Cardiovascular Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 7.7 Precision Medicine Drugs and Relevant Genes: Cardiovascular
Table 7.8 Precision Medicine Genetic Tests with Respect to Cardiovascular
Table 7.9 Key Developments
Table 7.10 Global CNS Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.11 Precision Medicine Drugs and Relevant Genes: Neurology
Table 7.12 Precision Medicine Drugs and Relevant Genes: Psychiatric Disorders
Table 7.13 Precision Medicine Genetic Tests with Respect to Psychiatric Disorders
Table 7.14 Psychiatric Disorders: Key Developments
Table 7.15 Global Infectious Disease Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.16 Precision Medicine Drugs and Relevant Genes: Infectious Diseases
Table 7.17 Key Developments
Table 7.18 Global Immunology Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.19 Global Other Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.20 Precision Medicine Drugs and Relevant Genes: Other Diseases
Table 7.21 Precision Medicine Genetic Tests with Respect to Other Diseases
Table 7.22 Key Developments
Table 8.1 Global Precision Medicine Market by Geography: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.2 North America Precision Medicine Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.3 Market Developments
Table 8.4 Europe Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.5 Market Developments
Table 8.6 APAC Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.7 Market Developments
Table 8.8 Middle East & Africa Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.9 Market Developments
Table 8.10 Latin America Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.11 Market Developments
Table 9.1 Key Factors Affecting the Bargaining Power of Suppliers
Table 9.2 Key Factors Affecting the Bargaining Power of Buyer
Table 9.3 Key Factors Affecting the Industry Rivalry
Table 9.4 Key Factors Affecting the Threat of New Entrants
Table 9.5 Key Factors Affecting the Threat of Substitutes
Table 10.1 Abbott Laboratories: Overview
Table 10.2 Abbott Laboratories: 5-year Revenue, Net Income, Operating Income ($ Mn)
Table 10.3 Abbott Laboratories: Key Developments
Table 10.4 GE Healthcare Overview
Table 10.5 GE Healthcare: 5-year Revenue, Profit ($ Mn)
Table 10.6 GE Healthcare: Key Developments
Table 10.7 GlaxoSmithKline plc: Overview
Table 10.8 GlaxoSmithKline plc: 5-year Revenue, Operating Profit, Profit After Tax ($ Mn)
Table 10.9 Johnson & Johnson: Overview
Table 10.10 Johnson & Johnson: 5-year Revenue, Net Earnings ($ Mn)
Table 10.11 Johnson & Johnson: Key Developments
Table 10.12 Pfizer Inc. Overview
Table 10.13 Pfizer Inc.: 5-year Revenue ($ Mn)
Table 10.14 Pfizer Inc: Key Developments
Table 10.15 Laboratory Corporation of America Holdings: Overview
Table 10.16 Laboratory Corporation of America Holdings: 5-year Revenue, Net Income, Operating Income ($ Mn)
Table 10.17 Laboratory Corporation: Key Developments
Table 10.18 Danaher Corporation: Overview
Table 10.19 Danaher Corporation: 5-year Revenue, Net Income, Operating Profit ($ Mn)
Table 10.20 Danaher Corporation: Key Developments
Table 10.21 QIAGEN: Overview
Table 10.22 QIAGEN: 5-year Revenue, Net Income ($ Mn)
Table 10.23 Thermo Fisher Scientific, Inc.: Overview
Table 10.24 Thermo Fisher Scientific, Inc.: 5-year Revenue, Net Income, Operating Income ($ Bn)
Table 10.25 Illumina, Inc.: Overview
Table 10.26 Illumina, Inc.: 5-year Revenue, Net Income, Operating Income ($bn)
Table 10.27 Novartis AG: Overview
Table 10.28 Novartis AG: 3-year Revenue, Net Income, Operating Income ($bn)
Table 11.1 Key Partnerships, Collaborations and Joint Ventures
Table 11.2 Key Product Developments
Table 11.3 Key Acquisitions
Table 11.4 Key Expansion
Table 11.5 Key Patents, Approvals and Certifications
Table 11.6 Key Other Events

List of Figures
Figure 1.1 Global Precision Medicine Market – Segmentation by Technology
Figure 1.2 Global Precision Medicine Market – Segmentation by End Users
Figure 1.3 Global Precision Medicine Market - Segmentation by Therapeutic Application
Figure 1.4 Global Precision Medicine Market - Segmentation by Geography
Figure 2.1 History of Precision Medicine
Figure 2.2 Key Areas of Application for Precision Medicine
Figure 2.3 Key Different Type of Data Used by Big Data Companies in Precision Medicine
Figure 2.4 Key Areas of Interest for Precision Medicine
Figure 3.1 Global Precision Medicine Market Share by End Users: Revenue ($bn), 2018-2029
Figure 3.2 Global Precision Medicine Market Size by Technology: Revenue ($bn), 2018-2029
Figure 3.3 Global Precision Medicine Market Size by Therapeutic Application: Revenue ($bn), 2018-2029
Figure 3.4 Global Precision Medicine Market Size by Geography: Revenue ($bn), 2019-2029
Figure 4.1 Key Difficulties Faced by Players of Precision Medicine Market due to Regulations and Standards
Figure 4.2 FDA’s Role in Precision Medicine
Figure 5.1 Global Precision Medicine Market by End Users
Figure 5.2 Role of Pharmaceuticals and Biotech Companies
Figure 5.3 Challenges Faced by Pharma & Biotech Companies
Figure 5.4 Diagnostic Tests Benefits for Stakeholders
Figure 5.5 Challenges Faced by Diagnostic Companies
Figure 5.6 Benefits of Big Data
Figure 5.7 Transformation of Medicine
Figure 5.8 Basic Ingredients Provided by Big Data for Precision Medicine
Figure 5.9 Challenges Faced by Big Data Companies
Figure 5.10 OECD Recommendations on The Governance of Clinical Trials
Figure 6.1 Types of Precision Medicine Sub-Market
Figure 6.2 Benefits of Companion Diagnostics
Figure 6.3 Function of Biomarkers
Figure 6.4 Biobanks Services
Figure 6.5 Development in PGx
Figure 6.6 Model Systems Used in PGx
Figure 6.7 Challenges of PGx Studies
Figure 6.8 Type of Molecular Diagnostics Test
Figure 6.9 Molecular Diagnostics: Application
Figure 6.10 Molecular Diagnostics: Benefits
Figure 8.1 Global Precision Medicine Market Classification by Geography
Figure 8.2 Key Drivers for Precision Medicine: North America
Figure 8.3 Objectives of the Precision Medicine Initiative
Figure 8.4 APAC: Market Challenges
Figure 9.1 Precision Medicine Market Porter’s Five Forces Analysis, 2018
Figure 9.2 Precision Medicine Market Value Chain
Figure 10.1 Abbott Laboratories: Sales by Business Segment (%), 2018
Figure 10.2 Abbott Laboratories: Sales by Region (%), 2018
Figure 10.3 GE Healthcare: Sales by Business Segment (%), 2017
Figure 10.4 GE Healthcare: Sales by Geography (%), 2017
Figure 10.5 GlaxoSmithKline plc: Sales by Business
Figure 10.6 GlaxoSmithKline plc: Sales by Region (%), 2017
Figure 10.7 Johnson & Johnson: Sales by Business Segment (%), 2017
Figure 10.8 Johnson & Johnson: Sales by Region (%), 2017
Figure 10.9 Pfizer Inc.: Sales by Business Segment (%), 2018
Figure 10.10 Pfizer Inc.: Sales by Region (%), 2018
Figure 10.11 Laboratory Corporation of America Holdings: Sales by Business Segment (%), 2017
Figure 10.12 Laboratory Corporation of America Holdings: Sales by Region (%), 2017
Figure 10.13 Danaher Corporation: Sales by Business Segment (%), 2017
Figure 10.14 Danaher Corporation: Sales by Region (%), 2017
Figure 10.15 QIAGEN: Sales by Business Segment (%), 2018
Figure 10.16 QIAGEN: Sales by Region (%), 2018
Figure 10.17 Thermofisher Scientific, Inc.: Sales by Business Segment (%), 2018
Figure 10.18 Thermofisher Scientific, Inc.: Sales by Region (%), 2018
Figure 10.19 Illumina, Inc.: Sales by Business Segment (%), 2017
Figure 10.20 Illumina, Inc.: Sales by Region (%), 2017
Figure 10.21 Novartis AG: Sales by Business Segment (%), 2018
Figure 10.22 Novartis AG: Sales by Region (%), 2018
Figure 11.1 Precision Medicine Market Key Development Strategies